Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy

By Giles A.R.   Rivard G.E.   Teitel J.   Walker I.  

Transfusion and Apheresis Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy

By Giles A.R.   Rivard G.E.   Teitel J.   Walker I.  

Transfusion Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Will gene therapy trump factor treatment in hemophilia?

By Rangarajan Savita   Aledort Louis  

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 43-48

Informa Healthcare

Access to resources Recommend Favorite

Anti-factor VIII Antibodies (Inhibitors) in Hemophilia A: In Dire Need of Basic and Therapeutic Research

By Kaveri Srini  

Clinical Reviews in Allergy and Immunology, Vol. 37, Iss. 2, 2009-10 ,pp. : 55-57

Humana Press, Inc

Access to resources Recommend Favorite

Availability of Clotting Factor Concentrates in Genetically Engineered Form

By van Aken W.G.  

Transfusion and Apheresis Science, Vol. 19, Iss. 1, 1998-03 ,pp. : 9-15

Elsevier

Access to resources Recommend Favorite